Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study
Completed
Conditions studied: Rheumatoid Arthritis
In brief
The CORRONA CERTAIN Sub-study of the Consortium of Rheumatology Researchers of North America, Inc. is a Sub-study of the CORRONA Data Collection Program. The CERTAIN Sub-study is designed to systematically collect and document use patterns, effectiveness, comparative effectiveness and safety of biologic agents used in the management of Rheumatoid Arthritis (RA).
Key facts
- Study ID
- NCT01625650
- Run by
- CorEvitas
- People needed
- 2795
- Starts
- 2010-10-01
- Expected to finish
- 2015-05-01
- Last updated by the study team
- 2018-08-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- The CORRONA CERTAIN Sub-study is particularly focused on understanding the effectiveness and safety of biologic medications. Male and female patients, who
- are at least 18 years of age;
- have a documented diagnosis of RA by their treating rheumatologist;
- have at least moderate disease activity; and
- are initiating a biologic agent that has not be used for their treatment in the past are eligible to participate.
- Moderate disease activity is defined by a CDAI score greater than 10.
You may not qualify if…
- Disease other than RA that do not meet the inclusion criteria
Where it is running
- The Center For Rheumatoligy — Albany, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.